Non Interventional Observational Study to Collect Data for the Effect of Switching to Neupro on Severity of Restless Leg Syndrome (RLS) Symptoms and Augmentation as Well as the Change in Treatment Regimen Used, in RLS Patients With Previous Augmentation.

Trial Profile

Non Interventional Observational Study to Collect Data for the Effect of Switching to Neupro on Severity of Restless Leg Syndrome (RLS) Symptoms and Augmentation as Well as the Change in Treatment Regimen Used, in RLS Patients With Previous Augmentation.

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Apr 2015

At a glance

  • Drugs Rotigotine (Primary)
  • Indications Restless legs syndrome
  • Focus Therapeutic Use
  • Acronyms AURORA
  • Sponsors UCB
  • Most Recent Events

    • 20 Apr 2015 Results presented at the 67th Annual Meeting of the American Academy of Neurology (AAN), according to a UCB media release.
    • 03 Sep 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 15 Aug 2013 Planned End Date changed from 1 Jul 2013 to 1 Aug 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top